Measuring neurotoxic metals in newborn and infant hair using a new laser method
Development of a novel laser ablation-ICP-MS method for time-resolved measurement of neurotoxic metals in newborn and infant hair
This study looks at how being around harmful metals like lead and arsenic might affect babies' growth and development by checking their hair samples, which helps us learn more about their exposure without any painful procedures.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10705132 on NIH RePORTER |
What this research studies
This research investigates how exposure to neurotoxic metals like lead and arsenic affects infants' development. By analyzing hair samples from newborns and infants, researchers can track metal exposure over time, providing insights into how these substances may impact health. The innovative laser ablation technique allows for precise measurement of metal levels in hair, making it easier to understand the timing and extent of exposure. This non-invasive method is particularly beneficial for pediatric populations, as it avoids the discomfort associated with blood draws.
Who could benefit from this research
Good fit: Ideal candidates for this research are newborns and infants up to 11 years old who may have been exposed to neurotoxic metals.
Not a fit: Patients who are older than 11 years or those who have not been exposed to neurotoxic metals may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention strategies for neurodevelopmental issues in children caused by environmental toxins.
How similar studies have performed: Previous research has successfully used hair analysis to study metal exposure, indicating that this approach has potential for meaningful insights.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Simpson, Christopher D — University of Washington
- Study coordinator: Simpson, Christopher D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.